Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allogeneic platelet-rich plasma (soluble platelet factors) is a cell-derived therapeutic product developed and manufactured by the Republican Research and Practical Center of Transfusion and Medical Biotechnologies in Belarus. It is composed of a concentrated extract of soluble growth factors and cytokines—such as PDGF, TGF-beta, and VEGF—derived from donor platelets. This formulation is designed to stimulate tissue regeneration, accelerate wound healing, and modulate inflammatory responses by providing essential signaling molecules to the site of injury. Classified as a cell-derived medical device, it has reached approved status in Belarus for clinical applications involving tissue repair and inflammation management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on allogeneic platelet-rich plasma (soluble platelet factors).